TITLE

RAS Blockade for Every Diabetic Patient: Pro and Con

AUTHOR(S)
RUILOPE, LUIS M.; SOLINI, ANNA
PUB. DATE
May 2011
SOURCE
Diabetes Care;May2011 Supplement 2, Vol. 34, pS320
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article describes the pros and cons of using renin-angiotensin system (RAS) inhibitors in diabetic people. Based on the European Society of Hypertension and the European Society of Cardiology guidelines, RAS suppressor is the first monotherapy that should be given to a diabetic patient with elevated blood pressure. The different aspects of RAS suppression are listed. There also concerns over the indication to the use of RAS. One of which is the nephroprotective effect in type 2 diabetic patients with normal albumin excretion rate.
ACCESSION #
61968032

 

Related Articles

  • Diuretic Treatment of Hypertension. GROSSMAN, EHUD; ANGELI, FABIO; VERDECCHIA, PAOLO; REBOLDI, GIANPAOLO // Diabetes Care;May2011 Supplement 2, Vol. 34, pS313 

    The article examines the role of diuretics as first-line drugs or add-on drugs in the context of the available antihypertensive armamentarium. Based on the guidelines of the European Society of Cardiology/European Society of Hypertension (ESC/ESH), thiazide diuretics are recommended as...

  • 2013 European Guidelines for Hypertension Management. Stergiou, George S. // Hospital Chronicles;2014 Supplement 1, Vol. 9, p142 

    The article discusses the hypertension management guidelines published by the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) in June 2013. Topics include the recommended assessment of the total risk of cardiovascular events, measurement of blood pressure, and...

  • Comprehensive Diabetes Care: The Whole Enchilada. Kuritzky, Louis // Internal Medicine Alert;3/29/2008, Vol. 30 Issue 6, p48 

    The article focuses on a study on diabetics which demonstrated that although glucocentric focus in diabetes produces microvascular benefits, dealing with the factors like blood pressure (BP), lipids, the renin-angiotensin system, and platelets benefits the patient.

  • Renal perfusion and the renal hemodynamic response to blocking the renin system in diabetes: are the forces leading to vasodilation and vasoconstriction linked? Lansang, M. Cecilia; Hollenberg, Norman K. // Diabetes;Jul2002, Vol. 51 Issue 7, p2025 

    In three groups of subjects, those with type 2 diabetes and nephropathy, those with type 1 diabetes without nephropathy, and healthy volunteers subjected to short-term hyperglycemia, we observed a counterintuitive relationship. In all three groups, baseline renal plasma flow (RPF) was positively...

  • Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Mezzano, Sergio; Droguett, Alejandra; Burgos, M. Eugenia; Ardiles, Leopoldo G.; Flores, Claudio A.; Aros, Claudio A.; Carlos, Italo; Vío, Carlos P.; Ruiz-Ortega, Marta; Egido, Jesús // Kidney International Supplement;Oct2003, Issue 86, p64 

    Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Background. The molecular mechanisms of renal injury in diabetic nephropathy (DN) are not completely understood, although inflammatory cells play a key role. The renin-angiotensin system (RAS) is...

  • Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry. Maggioni, Aldo P.; Anker, Stefan D.; Dahlström, Ulf; Filippatos, Gerasimos; Ponikowski, Piotr; Zannad, Faiez; Amir, Offer; Chioncel, Ovidiu; Leiro, Marisa Crespo; Drozdz, Jaroslaw; Erglis, Andrejs; Fazlibegovic, Emir; Fonseca, Candida; Fruhwald, Friedrich; Gatzov, Plamen; Goncalvesova, Eva; Hassanein, Mahmoud; Hradec, Jaromir; Kavoliuniene, Ausra; Lainscak, Mitja // European Journal of Heart Failure; 

    Aims To evaluate how recommendations of European guidelines regarding pharmacological and non-pharmacological treatments for heart failure (HF) are adopted in clinical practice. Methods and results The ESC-HF Long-Term Registry is a prospective, observational study conducted in 211 Cardiology...

  • The Munich Myocardial Infarction Registry. Schnell, Oliver; Otter, Wolfgang; Standl, Eberhard // Diabetes Care;Nov2009 Supplement, Vol. 32, pS326 

    The article focuses on the Munich Myocardial Infarction Registry which documents and assesses the management of acute myocardial infarction among hospital patients with diabetes. The registry confirmed that early treatment approaches for diabetes such as coronary angiography and stenting were...

  • Blood Pressure Control in Italian Essential Hypertensives Treated by General Practitioners. Giannattasio, Cristina; Cairo, Matteo; Cesana, Francesca; Alloni, Marta; Sormani, Paola; Colombo, Giulia; Grassi, Guido; Mancia, Giuseppe // American Journal of Hypertension;Nov2012, Vol. 25 Issue 11, p1182 

    BackgroundAdequate control of blood pressure (BP) is limited worldwide. This has serious consequences for public health because in hypertensive patients, uncontrolled BP is associated with a higher incidence of cardiovascular events, particularly stroke. The aim of this study was to investigate...

  • What is new in hypertension guidelines? Meric, Murat // Journal of Experimental & Clinical Medicine;Mar2014, Vol. 31 Issue 1, p7 

    In recent years, trials were published and a series of new evidences were presented in relation to hypertension (HT), requiring changes in guidelines. In the light of these studies, the European Society of Hypertension (ESH)/European Society of Cardiology (ESC) HT guideline which was published...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics